<VariationArchive VariationID="10833" VariationName="NM_004463.3(FGD1):c.944dup (p.Ala316fs)" VariationType="Duplication" Accession="VCV000010833" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25872" VariationID="10833">
      <GeneList>
        <Gene Symbol="FGD1" FullName="FYVE, RhoGEF and PH domain containing 1" GeneID="2245" HGNC_ID="HGNC:3663" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="54445454" stop="54496234" display_start="54445454" display_stop="54496234" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="54471886" stop="54522598" display_start="54471886" display_stop="54522598" Strand="-" />
          </Location>
          <OMIM>300546</OMIM>
          <Haploinsufficiency last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-05-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FGD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004463.3(FGD1):c.944dup (p.Ala316fs)</Name>
      <CanonicalSPDI>NC_000023.11:54470172:GGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="54470172" stop="54470173" display_start="54470172" display_stop="54470173" variantLength="1" positionVCF="54470172" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="54496605" stop="54496606" display_start="54496605" display_stop="54496606" variantLength="1" positionVCF="54496605" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>A316fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.54496610dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.54496610dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.54470177dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.54470177dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008054.1" sequenceAccession="NG_008054" sequenceVersion="1" change="g.30994dup">
            <Expression>NG_008054.1:g.30994dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004463.3" sequenceAccession="NM_004463" sequenceVersion="3" change="c.944dup" MANESelect="true">
            <Expression>NM_004463.3:c.944dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004454.2" sequenceAccession="NP_004454" sequenceVersion="2" change="p.Ala316fs">
            <Expression>NP_004454.2:p.Ala316fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004463.2" sequenceAccession="NM_004463" sequenceVersion="2" change="c.944dupC">
            <Expression>NM_004463.2:c.944dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300546.0010" DB="OMIM" />
        <XRef Type="rs" ID="1569541255" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004463.3(FGD1):c.944dup (p.Ala316fs) AND Aarskog syndrome" Accession="RCV000011580" Version="3">
        <ClassifiedConditionList TraitSetID="3026">
          <ClassifiedCondition DB="MedGen" ID="C0175701">Aarskog syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004463.3(FGD1):c.944dup (p.Ala316fs) AND not provided" Accession="RCV003555999" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-10" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17152066</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21739585</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23211637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25046119</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26029706</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4146757</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3026" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="15926" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aarskog syndrome</ElementValue>
                <XRef ID="Aarskog+Syndrome/58" DB="Genetic Alliance" />
                <XRef ID="14921002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog Scott syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aarskog-Scott syndrome, X-linked</ElementValue>
                <XRef ID="MONDO:0010589" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER</ElementValue>
                <XRef Type="Allelic variant" ID="300546.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300546.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FGDY</ElementValue>
                <XRef Type="MIM" ID="305400" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AAS</ElementValue>
                <XRef Type="MIM" ID="305400" DB="OMIM" />
              </Symbol>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21654724</ID>
              </Citation>
              <XRef ID="915" DB="Orphanet" />
              <XRef ID="C0175701" DB="MedGen" />
              <XRef ID="MONDO:0010589" DB="MONDO" />
              <XRef Type="MIM" ID="305400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31812" SubmissionDate="2021-07-09" DateLastUpdated="2021-07-13" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300546.0010_AARSKOG-SCOTT SYNDROME" title="FGD1, 1-BP INS, 945C_AARSKOG-SCOTT SYNDROME" />
        <ClinVarAccession Accession="SCV000031812" DateUpdated="2021-07-13" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers with features consistent with Aarskog-Scott syndrome (AAS; 305400), Orrico et al. (2007) identified a 1-bp insertion (945insC) in exon 4 of the FGD1 gene, predicted to cause truncation of the protein at codon 319. The brothers' phenotype included short stature, hypertelorism, shawl scrotum, brachydactyly with mild soft tissue webbing between the fingers, and normal intelligence. The older brother had unusually severe craniofacial abnormalities involving right hemifacial microsomia with right microtia. Their sister and mother, who also carried the mutation and had random X-inactivation patterns, exhibited short stature and joint laxity. All affected members of the family had a curved linear dimple beneath the lower lip, a feature noted in some of the earliest described patients (see Sugarman et al., 1973).</Attribute>
              <Citation>
                <ID Source="PubMed">17152066</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">4146757</ID>
              </Citation>
              <XRef DB="OMIM" ID="305400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGD1" />
          </GeneList>
          <Name>FGD1, 1-BP INS, 945C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 945C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300546.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AARSKOG-SCOTT SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7984378" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4972290|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004299570" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21739585</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23211637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25046119</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26029706</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17152066</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala316Cysfs*4) in the FGD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FGD1 are known to be pathogenic (PMID: 21739585, 23211637, 25046119, 26029706). This variant is not present in population databases (gnomAD no frequency). This variant is also known as c.945insC. This premature translational stop signal has been observed in individual(s) with Aarskog-Scott syndrome (PMID: 17152066). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 10833).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FGD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.54496605_54496606insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7984378" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="31812" TraitType="Disease" MappingType="Name" MappingValue="AARSKOG-SCOTT SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0175701" Name="Aarskog syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

